Status:
COMPLETED
Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer Pain
Eligibility:
All Genders
21+ years
Brief Summary
The purpose of this study is to modify the opioid titration order sheet to meet the needs of the outpatient hospice population and to conduct a pilot trial to assess feasibility, utility, and derive p...
Eligibility Criteria
Inclusion
- Patient eligibility includes:
- Alive Hospice outpatient
- Diagnosis of carcinoma
- Pain requiring fixed dose opioids
- Age \> 21 years
- Not pregnant or lactating
- Willing and able to sign informed consent
- Able to speak/comprehend English
- Caregiver eligibility will include:
- Caregiver for an Alive Hospice patient
- Willing and able to sign informed consent
- Able to speak/comprehend English
- Hospice Staff eligibility will include:
- Currently on staff at Alive Hospice
- Willing and able to sign informed consent
- Able to read/speak English.
- Referring Physician eligibility will include:
- Having recently referred patients to Alive Hospice
- Willing and able to sign informed consent and able to read/speak English.
Exclusion
- patients \< 21 years of age
- pregnant or lactating
- patients, caregiver and or Hospice staff that does not speak/comprehend English
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT01230515
Start Date
January 1 2006
End Date
March 1 2008
Last Update
September 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt-Ingam Cancer Center
Nashville, Tennessee, United States